ALEXANDRA VATZAKAS: Open Payments
NPI 1417316472 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$552 in 25 payments from 10 companies in 2025. Trend: 2023 $196 · 2024 $153 · 2025 $552
Food & beverage: $552
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 10 | $158 |
| Regeneron Healthcare Solutions, Inc. | 4 | $111 |
| Merck Sharp & Dohme LLC | 3 | $82 |
| 3B Medical, Inc. | 2 | $61 |
| GENZYME CORPORATION | 1 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Verona Pharma, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Baxter Healthcare | 1 | $19 |
| Pulmonx Corporation | 1 | $14 |
Products named: DUPIXENT, NUCALA, WINREVAIR, LUNA, ALUNBRIG, TRELEGY ELLIPTA, Ohtuvayre, OPSUMIT.
Industry payments across GA — which companies pay providers there.
